表皮生长因子受体-话题@MedSci

#表皮生长因子受体#

11篇内容 | 798人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2195447, encodeId=fcf5219544e5f, content=<a href='/topic/show?id=2c091125583a' target=_blank style='color:#2F92EE;'>#ELCC 2024#</a> <a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=ELCC 2024 ：EGFR和TP53双突变对非小细胞肺癌治疗和预后有着重要影响：韩国回顾性队列研究, objectType=article, longId=818053, objectId=59d1818053ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240326/1711437863816_8624274.png, objectUrl=/article/show_article.do?id=59d1818053ad, replyNumber=0, likeNumber=16, createdTime=2024-03-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=59d1818053ad, moduleTitle=ELCC 2024 ：EGFR和TP53双突变对非小细胞肺癌治疗和预后有着重要影响：韩国回顾性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59d1818053ad)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2185335, encodeId=2e992185335ef, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=0c8265e2b3' target=_blank style='color:#2F92EE;'>#EGFR-TKI#</a> <a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a> <a href='/topic/show?id=9f15110e82fc' target=_blank style='color:#2F92EE;'>#软脑膜转移#</a>, objectTitle=最全综述：初治和耐药EGFR突变非小细胞肺癌软脑膜转移患者的EGFR-TKI治疗选择和疗效, objectType=article, longId=811862, objectId=008d8118625b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/close-up-of-doctors-with-clipboard-at-hospital-PXE5DKE.jpg, objectUrl=/article/show_article.do?id=008d8118625b, replyNumber=0, likeNumber=31, createdTime=2024-02-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=008d8118625b, moduleTitle=最全综述：初治和耐药EGFR突变非小细胞肺癌软脑膜转移患者的EGFR-TKI治疗选择和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=008d8118625b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1663630, encodeId=4d2816636308a, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=JAMA Oncol：抗表皮生长因子受体抗体药物偶联物MRG003治疗晚期实体瘤, objectType=article, longId=727924, objectId=0dbbe2792428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dbbe2792428, replyNumber=0, likeNumber=39, createdTime=2022-06-20, rootId=0, userName=ms9608593228839890, userId=a88a25636997, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dbbe2792428, moduleTitle=JAMA Oncol：抗表皮生长因子受体抗体药物偶联物MRG003治疗晚期实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dbbe2792428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663629, encodeId=7b5b16636297b, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=Front Oncol：左侧RAS/BRAF野生型转移性结直肠癌(mCRC)患者一线抗表皮生长因子受体(EGFR)为基础治疗后后续维持治疗管理, objectType=article, longId=219570, objectId=1d282195e0e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d282195e0e7, replyNumber=0, likeNumber=31, createdTime=2022-03-23, rootId=0, userName=ms9608593228839890, userId=a88a25636997, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d282195e0e7, moduleTitle=Front Oncol：左侧RAS/BRAF野生型转移性结直肠癌(mCRC)患者一线抗表皮生长因子受体(EGFR)为基础治疗后后续维持治疗管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d282195e0e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663628, encodeId=7fc0166362859, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=J Clin Oncol：辅助紫杉醇和曲妥珠单抗试验治疗结节阴性、人表皮生长因子受体2阳性乳腺癌的七年随访分析, objectType=article, longId=195901, objectId=b90719590192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b90719590192, replyNumber=0, likeNumber=39, createdTime=2020-12-13, rootId=0, userName=ms9608593228839890, userId=a88a25636997, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b90719590192, moduleTitle=J Clin Oncol：辅助紫杉醇和曲妥珠单抗试验治疗结节阴性、人表皮生长因子受体2阳性乳腺癌的七年随访分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b90719590192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663627, encodeId=5285166362ebb, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果, objectType=article, longId=195894, objectId=347c195894a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=347c195894a4, replyNumber=0, likeNumber=40, createdTime=2021-05-08, rootId=0, userName=ms9608593228839890, userId=a88a25636997, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=347c195894a4, moduleTitle=Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=347c195894a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663626, encodeId=dcf3166362689, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析, objectType=article, longId=159143, objectId=231c15914303, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=231c15914303, replyNumber=0, likeNumber=32, createdTime=2019-07-12, rootId=0, userName=ms9608593228839890, userId=a88a25636997, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=231c15914303, moduleTitle=2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=231c15914303)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663625, encodeId=ad221663625b9, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=Gut：表皮生长因子受体抑制剂对幽门螺杆菌诱导上皮细胞炎症、DNA损伤及胃癌的预防, objectType=article, longId=97962, objectId=3a689e962e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a689e962e2, replyNumber=0, likeNumber=45, createdTime=2017-07-21, rootId=0, userName=ms9608593228839890, userId=a88a25636997, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a689e962e2, moduleTitle=Gut：表皮生长因子受体抑制剂对幽门螺杆菌诱导上皮细胞炎症、DNA损伤及胃癌的预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a689e962e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663624, encodeId=c9821663624f3, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=Oncotarget：在预测TIG3膀胱癌结果中，人类表皮生长因子受体2表达比卡介苗处理更为重要, objectType=article, longId=97631, objectId=99059e63151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99059e63151, replyNumber=0, likeNumber=48, createdTime=2018-02-25, rootId=0, userName=ms9608593228839890, userId=a88a25636997, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99059e63151, moduleTitle=Oncotarget：在预测TIG3膀胱癌结果中，人类表皮生长因子受体2表达比卡介苗处理更为重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99059e63151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663623, encodeId=9e8a166362330, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=2015中国表皮生长因子受体基因敏感性突变和间变淋巴瘤激酶融合基因阳性非小细胞肺癌诊断治疗指南发布, objectType=article, longId=77551, objectId=078de755107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=078de755107, replyNumber=0, likeNumber=32, createdTime=2017-01-13, rootId=0, userName=ms9608593228839890, userId=a88a25636997, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=078de755107, moduleTitle=2015中国表皮生长因子受体基因敏感性突变和间变淋巴瘤激酶融合基因阳性非小细胞肺癌诊断治疗指南发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=078de755107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663622, encodeId=457116636225b, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=2016中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家共识发布, objectType=article, longId=76284, objectId=27d7e62840f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27d7e62840f, replyNumber=0, likeNumber=30, createdTime=2017-05-16, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27d7e62840f, moduleTitle=2016中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27d7e62840f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663621, encodeId=1c4f166362182, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=Gynecol Oncol：吉非替尼联合S-1与卡铂一线治疗发生表皮生长因子受体突变的晚期非小细胞肺癌患者的II期临床试验, objectType=article, longId=37047, objectId=6eb73e0471c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6eb73e0471c, replyNumber=0, likeNumber=38, createdTime=2015-05-28, rootId=0, userName=ms9608593228839890, userId=a88a25636997, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6eb73e0471c, moduleTitle=Gynecol Oncol：吉非替尼联合S-1与卡铂一线治疗发生表皮生长因子受体突变的晚期非小细胞肺癌患者的II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6eb73e0471c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663620, encodeId=e0dd1663620d5, content=<a href='/topic/show?id=84c4902325a' target=_blank style='color:#2F92EE;'>#表皮生长因子受体#</a>, objectTitle=中国表皮生长因子受体基因突变和间变淋巴瘤激酶融合基因阳性非小细胞肺癌诊断治疗指南(2013版), objectType=article, longId=30242, objectId=e02930242df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e02930242df, replyNumber=0, likeNumber=43, createdTime=2015-01-04, rootId=0, userName=ms9608593228839890, userId=a88a25636997, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e02930242df, moduleTitle=中国表皮生长因子受体基因突变和间变淋巴瘤激酶融合基因阳性非小细胞肺癌诊断治疗指南(2013版), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e02930242df)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

表皮生长因子受体

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#ELCC 2024# #非小细胞肺癌# #表皮生长因子受体#

ELCC 2024 ：EGFR和TP53双突变对非小细胞肺癌治疗和预后有着重要影响：韩国回顾性队列研究

2024-03-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#非小细胞肺癌# #EGFR-TKI# #表皮生长因子受体# #软脑膜转移#

最全综述：初治和耐药EGFR突变非小细胞肺癌软脑膜转移患者的EGFR-TKI治疗选择和疗效

2024-02-01发表于陕西省

ms9608593228839890 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

JAMA Oncol：抗表皮生长因子受体抗体药物偶联物MRG003治疗晚期实体瘤

2022-06-20

ms9608593228839890 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

Front Oncol：左侧RAS/BRAF野生型转移性结直肠癌(mCRC)患者一线抗表皮生长因子受体(EGFR)为基础治疗后后续维持治疗管理

2022-03-23

ms9608593228839890 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

J Clin Oncol：辅助紫杉醇和曲妥珠单抗试验治疗结节阴性、人表皮生长因子受体2阳性乳腺癌的七年随访分析

2020-12-13

ms9608593228839890 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果

2021-05-08

ms9608593228839890 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析

2019-07-12

ms9608593228839890 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

Gut：表皮生长因子受体抑制剂对幽门螺杆菌诱导上皮细胞炎症、DNA损伤及胃癌的预防

2017-07-21

ms9608593228839890 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

Oncotarget：在预测TIG3膀胱癌结果中，人类表皮生长因子受体2表达比卡介苗处理更为重要

2018-02-25

ms9608593228839890 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

2015中国表皮生长因子受体基因敏感性突变和间变淋巴瘤激酶融合基因阳性非小细胞肺癌诊断治疗指南发布

2017-01-13

爆笑小医 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

2016中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家共识发布

2017-05-16

ms9608593228839890 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

Gynecol Oncol：吉非替尼联合S-1与卡铂一线治疗发生表皮生长因子受体突变的晚期非小细胞肺癌患者的II期临床试验

2015-05-28

ms9608593228839890 (审核中...)

前往app查看评论内容

#表皮生长因子受体#

中国表皮生长因子受体基因突变和间变淋巴瘤激酶融合基因阳性非小细胞肺癌诊断治疗指南(2013版)

2015-01-04

科室
- - 订阅+
  - 更多科室
工具
服务